{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:21:11Z","timestamp":1739942471557,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.7759\/cureus.79243","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:17:16Z","timestamp":1739909836000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Elevated CRP Levels as an Infection Marker: Implications for Chemotherapy Cycles in Lung Cancer Patients"],"prefix":"10.7759","author":[{"given":"Emine Sevil","family":"Ayaydin Murtezaoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tevfik","family":"Ozlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.114","article-title":"A prospective study of infections in lung cancer patients admitted to the hospital","volume":"124","author":"Berghmans T","year":"2003","unstructured":"Berghmans T, Sculier JP, Klastersky J. A prospective study of infections in lung cancer patients admitted to the hospital. Chest. 2003, 124:114-20. 10.1378\/chest.124.1.114","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1984.tb00919.x","article-title":"Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases","volume":"19","author":"Weinstein PS","year":"1984","unstructured":"Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS. Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol. 1984, 19:193-8. 10.1111\/j.1365-3083.1984.tb00919.x","journal-title":"Scand J Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-007-0381-1","article-title":"Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders","volume":"16","author":"Dornbusch HJ","year":"2008","unstructured":"Dornbusch HJ, Strenger V, Sovinz P, Lackner H, Schwinger W, Kerbl R, Urban C. Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders. Support Care Cancer. 2008, 16:1035-40. 10.1007\/s00520-007-0381-1","journal-title":"Support Care Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac544.299","article-title":"Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction","volume":"43","author":"Holzknecht M","year":"2022","unstructured":"Holzknecht M, Lechner I, Reindl M, et al.. Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction. Eur. Heart J. 2022, 43:10.1093\/eurheartj\/ehac544.299","journal-title":"Eur. Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix C","year":"2022","unstructured":"Dix C, Zeller J, Stevens H, et al.. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol. 2022, 13:1002652. 10.3389\/fimmu.2022.1002652","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw P","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al.. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016, 11:39-51. 10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.197","article-title":"Acute phase reaction during chemotherapy in small cell lung cancer","volume":"59","author":"Milroy R","year":"1989","unstructured":"Milroy R, Shapiro D, Shenkin A, Banham SW. Acute phase reaction during chemotherapy in small cell lung cancer. Br J Cancer. 1989, 59:933-5. 10.1038\/bjc.1989.197","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011930","article-title":"Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients","volume":"97","author":"Zhao Z","year":"2018","unstructured":"Zhao Z, Li X, Zhao Y, et al.. Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients. Medicine. 2018, 97:10.1097\/MD.0000000000011930","journal-title":"Medicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5505\/tjoncol.2014.655","article-title":"The effects of chemotherapy on C-reactive protein and quality of life in cancer patients (Article in Turkish)","volume":"10","author":"G\u00fcrler MY","year":"2014","unstructured":"G\u00fcrler MY, Demir G, Moueminoglou F, Apaydin S, L\u00fcy N. The effects of chemotherapy on C-reactive protein and quality of life in cancer patients (Article in Turkish). Turk Onkoloji Dergisi. 2014, 10:5505. 10.5505\/tjoncol.2014.655","journal-title":"Turk Onkoloji Dergisi"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2015.134","article-title":"Procalcitonin is not useful to discriminate between infectious and noninfectious CRP elevation in patients with non-small cell lung cancer","volume":"36","author":"Scheinpflug K","year":"2015","unstructured":"Scheinpflug K, Schalk E, Grabert E, Achenbach HJ. Procalcitonin is not useful to discriminate between infectious and noninfectious CRP elevation in patients with non-small cell lung cancer. Infect Control Hosp Epidemiol. 2015, 36:1117-8. 10.1017\/ice.2015.134","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/505394","article-title":"Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations","volume":"43","author":"Schuttrumpf S","year":"2006","unstructured":"Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C. Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis. 2006, 43:468-73. 10.1086\/505394","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2013.33777","article-title":"Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients","volume":"17","author":"Tulek B","year":"2013","unstructured":"Tulek B, Koylu H, Kanat F, Arslan U, Ozer F. Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients. Contemp Oncol. 2013, 17:68-72. 10.5114\/wo.2013.33777","journal-title":"Contemp Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0584-y","article-title":"Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?","volume":"82","author":"Sch\u00fcttrumpf S","year":"2003","unstructured":"Sch\u00fcttrumpf S, Binder L, Hagemann T, Berkovic D, Tr\u00fcmper L, Binder C. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?. Ann Hematol. 2003, 82:98-103. 10.1007\/s00277-002-0584-y","journal-title":"Ann Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7070160","article-title":"Relationship between inflammatory and biological markers and lung cancer","volume":"7","author":"\u015eahin F","year":"2018","unstructured":"\u015eahin F, Aslan AF. Relationship between inflammatory and biological markers and lung cancer. J Clin Med. 2018, 7:10.3390\/jcm7070160","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000506204","article-title":"Impact of age on inflammation-based scores among patients diagnosed with stage III non-small cell lung cancer","volume":"98","author":"Palomar-Abril V","year":"2020","unstructured":"Palomar-Abril V, Soria-Comes T, Tarazona Campos S, Mart\u00edn Ureste M, Giner Bosch V, Maestu Maiques IC. Impact of age on inflammation-based scores among patients diagnosed with stage III non-small cell lung cancer. Oncology. 2020, 98:528-33. 10.1159\/000506204","journal-title":"Oncology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.173.405","article-title":"The pattern of respiratory infection in patients with lung cancer","volume":"173","author":"Kohno S","year":"1994","unstructured":"Kohno S, Koga H, Oka M, et al.. The pattern of respiratory infection in patients with lung cancer. Tohoku J Exp Med. 1994, 173:405-11. 10.1620\/tjem.173.405","journal-title":"Tohoku J Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340771-evaluating-elevated-crp-levels-as-an-infection-marker-implications-for-chemotherapy-cycles-in-lung-cancer-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:17:18Z","timestamp":1739909838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340771-evaluating-elevated-crp-levels-as-an-infection-marker-implications-for-chemotherapy-cycles-in-lung-cancer-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.79243","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}